After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
CUET UG 2022: Is there a conspiracy against CUET, know why exams have to be canceled
Common University Entrance Test i.e. CUET UG 2022 is being conducted for admission to undergradua
On the night of the incident, when the Kolkata rape victim had a panic attack and pleaded to be t
Team India defeated West Indies by 119 runs in the third ODI to clean sweep the series 3-0. The I
The truth cannot be hidden for long. No matter how much Turkey and China, which are facing allega
Lok Sabha Speaker Om Birla addressed the participants at the closing ceremony of the 36th Nationa
Pakistan's ruling coalition PDM begins talks with PTI to resolve the political crisis
For the first time after coming to power, the federal government led by the Pakistan Democratic M
Ukraine-Russia War: Between the ongoing war in Russia and Ukraine, there are some optimistic sign
Goods Barometer: Signs of the global economy slowing down in 2023, what do WTO figures say?
Global trade growth is likely to slow down in the latter months of 2022 and 2023 as the world eco
After Operation Sindoor, the central government has formed a team which will go to different coun
India entered the final by registering a win against England on Thursday. Team India defeated Eng
